Literature DB >> 7504216

Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons.

N B Mercuri1, F Stratta, P Calabresi, A Bonci, G Bernardi.   

Abstract

To investigate the electrophysiological effects of the stimulation of the metabotropic excitatory amino acid receptors, we applied trans-1-amino-cyclopentane-1,3-dicarboxylate, an agonist of this type of receptors, on presumed rat dopamine cells intracellularly recorded in vitro. Trans-1-amino-cyclopentane-1,3-dicarboxylate (3-30 microM, t-ACPD) caused a sustained increase of the spontaneous firing rate and a depolarization. When the membrane potential was held at about the resting level (-50, -60 mV), by the single-electrode voltage-clamp technique, t-ACPD induced an inward current. In 57% of the tested cells the inward current was associated with a decrease of the apparent input conductance. In the remaining cells no obvious changes in membrane conductance were observed. The active form of t-ACPD, (1S,3R)-1-amino-cyclopentane-1,3-dicarboxylate [3-50 microM, (1S,3R)-ACPD] also produced a reversible inward current on the dopaminergic cells and this was antagonized by (S)-4-carboxy-3-hydroxyphenylglycine (300 microM), a selective antagonist of the (1S,3R)-ACPD-induced depolarization on central neurons. The (1S,3R)-ACPD-induced inward current was not antagonized by L-2-amino-3-phosphonopropionic acid (100 microM), an antagonist of the t-ACPD-induced activation of inositide synthesis. 6-cyano-7-nitroquinoxaline-2,3-dione (10 microM), an alfa-amino-3-hydroxy-5- methyl-isoxazole propionic acid/kainate antagonist, DL-amino-5-phosphonopentanoic acid (30 microM), an N-methyl-D-aspartate antagonist, and scopolamine (10 microM), a muscarinic antagonist, did not significantly affect the actions of t-ACPD. A block of synaptic transmission obtained by applying tetrodotoxin failed to prevent the action of t-ACPD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504216     DOI: 10.1016/0306-4522(93)90341-c

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  A long-lasting calcium-activated nonselective cationic current is generated by synaptic stimulation or exogenous activation of group I metabotropic glutamate receptors in CA1 pyramidal neurons.

Authors:  P Congar; X Leinekugel; Y Ben-Ari; V Crépel
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex.

Authors:  Z Y Tong; P G Overton; D Clark
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

Authors:  Shinnyi Chou; Collin Davis; Sean Jones; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2014-11-26       Impact factor: 3.533

4.  Quisqualate-preferring metabotropic glutamate receptor activates Na(+)-Ca2+ exchange in rat basolateral amygdala neurones.

Authors:  N B Keele; V L Arvanov; P Shinnick-Gallagher
Journal:  J Physiol       Date:  1997-02-15       Impact factor: 5.182

5.  Glutamate inhibits thalamic reticular neurons.

Authors:  C L Cox; S M Sherman
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q).

Authors:  Sudarat Nimitvilai; Maureen A McElvain; Devinder S Arora; Mark S Brodie
Journal:  J Neurophysiol       Date:  2012-04-04       Impact factor: 2.714

7.  PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.

Authors:  Graziella Madeo; Tommaso Schirinzi; Giuseppina Martella; E Claudio Latagliata; Francesca Puglisi; Jie Shen; Enza Maria Valente; Mauro Federici; Nicola B Mercuri; Stefano Puglisi-Allegra; Paola Bonsi; Antonio Pisani
Journal:  Mov Disord       Date:  2013-10-25       Impact factor: 10.338

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.